Synchronized dog vaccinations to prevent human rabies in Africa
Improving dog vaccinations: a development and feasibility study to pave the way for effective, synchronized dog vaccination campaigns in Africa
This project will try coordinated media campaigns plus one-day, synchronized dog vaccination drives to boost dog vaccination rates and lower the risk of rabies for people in affected African communities.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ifakara Health Institute NIH-funded |
| Lab location | 1 site (Dar-Es-Salaam, Tanzania U Rep) |
| Project ID | NIH-11193494 on NIH RePORTER |
What this research studies
From a local resident's view, the team will organize one-day, district-wide dog vaccination events timed across many villages and promote them with mass media before the day. They will compare this synchronized approach to the usual multi-day, team-led village-by-village campaigns to see which reaches more dogs. The project includes community outreach, tracking how many dogs are vaccinated, and checking whether owners bring their pets on the vaccination day. The aim is to test whether this combined media-plus-synchronized approach is practical and can reach the 70% dog vaccination coverage needed to stop rabies spread.
Who could benefit from this research
Good fit: Ideal participants are dog owners and household members living in the communities selected for the vaccination campaigns who can bring their dogs to the scheduled vaccination events.
Not a fit: People who do not own or care for dogs, live outside the campaign areas, or cannot bring their dogs to the vaccination sites may not receive direct benefit from the campaign.
Why it matters
Potential benefit: If successful, this could lower dog-mediated human rabies cases by increasing dog vaccination coverage and making communities safer from deadly rabies infections.
How similar studies have performed: Synchronized vaccination campaigns combined with media outreach have worked well in Latin America, but this approach is relatively untested at scale in East African settings.
Where this research is happening
Dar-Es-Salaam, Tanzania U Rep
- Ifakara Health Institute — Dar-Es-Salaam, Tanzania U Rep (Active)
Researchers
- Principal investigator: Maganga, Sambo Burton — Ifakara Health Institute
- Study coordinator: Maganga, Sambo Burton
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.